Clinical Trial Update: TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion and posting of results for TBTC Study 31, a Phase 3 trial evaluating rifapentine-containing regimens to shorte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• rifapentine (rifapentine)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Tuberculosis | Phase 3 | Status: COMPLETED | Results posted: 2021-09-28